sST2 as a New Biomarker of Chronic Kidney Disease-Induced Cardiac Remodeling: Impact on Risk Prediction

Figure 3

Barcelona Bio-HF score and composite outcome prediction. Event-free survival probability according to mortality risk predicted by the Barcelona Bio-Heart Failure score. Study population was stratified by quartiles of 1-year mortality risk (Q1: risk < 1.56%, Q2: 1.56 ≤ risk < 3.45%, Q3: 3.45 ≤ risk < 6.68%, and Q4: risk > 6.68%). value refers to the log-rank test.